Pharma Capsules - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharma Capsules

Pharmaceutical Technology

Clondalkin Group (Amsterdam, The Netherlands), a producer of packaging products in Europe and the United States, acquired Keller Crescent Co. (Evansville, IN). Details of the transaction were not released.

Keller Crescent produces packaging components, including folding cartons, labels, inserts, and outserts. The company will retain its name and will become part of Clondalkin's North American packaging operations, which consists of 14 manufacturing facilities in seven states and Puerto Rico.

SGS India Passes FDA's QC Testing Inspection

SGS India Private Ltd. (Chennai, formerly Madras) received a notification letter from the US Food and Drug Administration (Rockville, MD) regarding its "acceptable" classification resulting from an FDA inspection conducted in Feb. 2007. This was the first FDA inspection of the SGS quality-control testing laboratory in Chennai. It was both a preapproval inspection and a good manufacturing practices inspection.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here